Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
about
MicroRNAs as Biomarkers for Liver Disease and Hepatocellular CarcinomaHypermethylation of miR-203 in endometrial carcinomas.A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma.Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters.Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4.Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma.DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.The "Macro" World of microRNAs in Hepatocellular Carcinoma.Genome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis.A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.Regulation of Nuclear Receptor Nur77 by miR-124.MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation.Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs.Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma.Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.The CpG island methylator phenotype in breast cancer is associated with the lobular subtype.Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.Effects of potentially functional polymorphisms in suppressor of cytokine signaling 3 (SOCS3) on the risk of head and neck squamous cancer.HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas.MicroRNA-27a directly targets KRAS to inhibit cell proliferation in esophageal squamous cell carcinoma.Epigenetic impacts of ascorbate on human metastatic melanoma cells.miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer
P2860
Q26765476-84FE3C7C-A583-45EE-BC11-AEFFCDDFE463Q33586571-2A905ED2-D4FF-4E0D-9208-975C67C82E8DQ33858517-1FFF027A-C746-459E-90F8-5B7603009313Q34956940-BEB80AB8-AC6C-4D47-BBC9-9C1642E63001Q34982573-3217DD33-BCED-4C9D-833B-770B40251BD3Q35169860-59020EE4-F1B0-430A-9CD9-541A1C4A2174Q35197356-53FADB58-947B-40D6-8047-587DAE3BBD94Q35215896-FA5C4DA4-A04E-4A9C-B714-4F5F77585D09Q35227134-154EF7DC-69AE-49B1-9D52-5D34F068207DQ35654057-A97D4192-BE16-464E-8284-3037B8B80EE5Q35752063-152E3061-FC3D-406B-A904-27D1AFAF42D0Q35913193-24B934D7-BCC3-47BD-963E-B8EECE982979Q35981607-EA119B08-2C97-48D5-A66D-39E9B424993CQ36561669-9361C1CF-2FEF-46DD-8306-D091BC0CA7CDQ37392871-63B4DFEC-79F5-4DCC-8B61-30F356D21367Q37439272-42153058-5810-44FD-BEFF-AE62AF698705Q37536706-0BC24A8D-27B1-48A7-A64B-5F4778F7A39DQ37685458-92DCC62E-1256-4FEE-AB5A-C5F716302F58Q37701611-FC806DE1-B0E9-4798-B82D-CCE85EBFF09EQ38714556-8AF78F0D-41C7-4589-8724-6F8570398C3DQ38800435-57227923-77AC-4967-AF6B-DF0A212AD1E4Q38944944-03F3E481-A276-4D3E-B5DD-8EDEDC2B9834Q38994050-F2A00620-9E45-499B-BEC6-C02D8C93D4E7Q40423794-922F9648-43C5-408E-819D-68F0E1A2B9FCQ41470046-5AC611A7-7759-48A0-A73A-687C65C6F2DEQ41850618-33631567-46FA-4015-BD20-420E5D5352BAQ42002131-E997C34E-0D65-4A54-8964-D832BE28A111Q42051478-4E0EFBF0-4171-4A4A-B3D2-D60907D986D3Q55139983-52D33E7A-063A-45B4-9176-BC956123BC0EQ58766654-4F2414D9-11BC-4D6F-AFCC-5FBBC03EB014
P2860
Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Concordant hypermethylation of ...... gnostic and prognostic marker.
@en
Concordant hypermethylation of ...... gnostic and prognostic marker.
@nl
type
label
Concordant hypermethylation of ...... gnostic and prognostic marker.
@en
Concordant hypermethylation of ...... gnostic and prognostic marker.
@nl
prefLabel
Concordant hypermethylation of ...... gnostic and prognostic marker.
@en
Concordant hypermethylation of ...... gnostic and prognostic marker.
@nl
P2093
P2860
P356
P1476
Concordant hypermethylation of ...... agnostic and prognostic marker
@en
P2093
Arndt Vogel
Britta Hasemeier
Cord Albat
Elisa Schipper
Hans Kreipe
Nora Schweitzer
Till Krech
Ulrich Lehmann
P2860
P304
P356
10.1002/IJC.28068
P577
2013-03-04T00:00:00Z